查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466074

連續血糖監測系統市場：按組件、人口統計、患者類型、最終用戶、分銷管道 - 全球預測 2024-2030

Continuous Glucose Monitoring Systems Market by Component (Integrated Insulin Pumps, Sensors, Transmitters & Receivers), Demographics (Adult Population, Children Population), Patient Type, End User, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年連續血糖監測系統市場規模為55.4億美元，預計2024年將達62.1億美元，2030年將達到125.5億美元，複合年成長率為12.37%。

連續血糖監測系統 (CGMS) 是一種先進的醫療設備，旨在定期（通常每隔幾分鐘、每天 24 小時、一年 365 天）提供即時血糖讀數。這些系統由小型感測器組成，可將資料無線傳輸到專用接收器、智慧型手機、智慧型手錶或其他顯示設備，使用戶無需進行傳統的手指血液測試即可監測血糖濃度。全球糖尿病患者數量不斷增加，以及人們日益認知到連續血糖值監測優於傳統血糖監測，推動了市場成長。然而，該設備的高價格和缺乏統一報銷可能會限制市場滲透。由於設備校準問題和外部因素干擾導致的葡萄糖測量不準確也是一個挑戰。此外，利用巨量資料和進階分析來提高預測能力、個人化和臨床結果，為市場成長創造了潛在的機會。

主要市場統計
基準年[2023] 55.4億美元
預測年份 [2024] 62.1億美元
預測年份 [2030] 125.5億美元
複合年成長率（%） 12.37%

組件 在 CGM 系統中增加使用發射器和接收器進行即時血糖監測

整合胰島素幫浦是一種根據設定的基礎血糖值自動輸送胰島素的設備，並與連續血糖監測 (CGM) 系統配合使用。胰島素幫浦根據即時血糖測量調整胰島素輸送。這項功能極大地有助於糖尿病患者血糖值的無縫管理，對於需要強化胰島素治療的患者和 1 型糖尿病患者尤其有用。該感測器是 CGM 系統的重要組成部分，因為它是測量皮下間質液中血糖濃度的組件。 CGM 感測器通常需要每 7 到 14 天更換一次，具體取決於型號。想要最小侵入和較長佩戴時間的患者更喜歡長壽命感測器。發送器是 CGM 系統的一部分，用於將即時血糖資料從感測器傳輸到接收器和智慧型裝置。接收器是顯示葡萄糖資料的裝置。有些患者喜歡允許他們使用智慧型手機作為接收器的系統，而有些患者如果不喜歡使用智慧型設備，則喜歡專用設備。

人口統計：更有效、更侵入性的兒童用CGM 系統的持續進步

連續血糖監測 (CGM) 系統對於成年人極為重要，尤其是那些被診斷出患有第 1 型或第 2 型糖尿病的成年人。成年人需要持續準確地監測血糖值，以有效管理自己的病情並預防與糖尿病相關的急性和長期併發症。兒童用CGM 系統根據兒童人群獨特的生理和生活方式要求，在尺寸、靈敏度和易用性方面進行了專門設計。這些設備可幫助父母和看護者更有效地監測和管理孩子的糖尿病，讓他們安心並提高生活品質。

患者類型：CGM 系統在第 1 型糖尿病患者中的重要性日益增加：準確度高、時滯短、血糖快速變化的預測警報

由於胰臟中產生胰島素的 BETA 細胞受到自體免疫破壞，1 型糖尿病患者依賴外部胰島素。連續血糖監測（CGM）系統為這群人提供了便利，也是血糖濃度管理的重要工具。這些患者需要即時資料來準確調整胰島素劑量。 CGM 系統比傳統血糖監測具有顯著優勢，可以詳細了解血糖趨勢，從而更好地控制血糖並降低低血糖風險。 2 型糖尿病患者應監測血糖濃度，尤其是在服用磺醯尿素或Meglitinides藥物時，這些藥物並不總是需要胰島素，但會增加低血糖的風險。 2型糖尿病的CGM旨在管理生活習慣，除了藥物治療外，還包括飲食和運動療法。隨著 CGM 技術變得越來越便宜，並且越來越多的證據表明它可以幫助改善未接受胰島素治療的患者的血糖控制，CGM 的使用在這群人中變得越來越普遍。

最終用戶：具有遠端資料共用功能的家庭患者越來越偏好 CGM 系統

診斷中心和診所是連續血糖監測 (CGM) 系統部署的重要組成部分。這些設施通常是出現糖尿病症狀或需要持續監測診斷病情的患者的第一個接觸點。家庭醫療保健是 CGM 系統快速成長的領域，因為越來越多的糖尿病患者更喜歡在舒適的家中管理糖尿病。這些設備非常方便，可以進行連續監測，而無需頻繁拜訪您的醫療保健提供者。加護病房(ICU) 是一個至關重要的環境，病患需要隨時密切監測，包括血糖濃度。 ICU CGM 系統需要可靠並與其他監測設備整合，以全面了解患者的健康狀況。

區域洞察

以美國和加拿大為中心的美洲地區是 CGM 系統的強大市場，並得到高購買力和採用最新技術的成熟醫療保健系統的支持。美國和加拿大在CGM技術領域處於領先地位，有許多公司在研究和開發新系統，該領域申請的專利數量證明了這一點。美國消費者更有可能維持健康的生活方式，並將個人健康科技融入日常生活中。大量投資和保險覆蓋促進了 CGM 系統的使用，使公眾更容易使用它們。歐盟（EU）國家對 CGM 系統表現出強勁需求，該系統得到廣泛認可，促進糖尿病生活方式管理，並得到有利的保險報銷方案的支持。歐盟的醫療設備產業受到嚴格監管，確保產品品質和安全的高標準。德國、法國和英國等國家是實施 CGM 系統的領先國家。中東地區，特別是波灣合作理事會（GCC）國家，人均醫療保健支出較高，並且正在迅速採用先進的醫療保健技術。由於糖尿病盛行率不斷上升以及人們對糖尿病的認知不斷提高，亞太地區對 CGM 系統的需求正在迅速成長。用於健康監測的穿戴式技術的日益普及表明亞太地區消費者對方便且非侵入式醫療保健設備的廣泛需求。

FPNV定位矩陣

FPNV定位矩陣對於評估連續血糖監測系統市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對連續血糖監測系統市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.連續血糖監測系統市場的市場規模與預測是多少？

2.在連續血糖監測系統市場的預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.連續血糖監測系統市場的技術趨勢和法規結構是什麼？

4.連續血糖監測系統市場主要供應商的市場佔有率為何？

5. 進入血糖連續監測系統市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球糖尿病患者數量不斷增加
      • 增加對 CGM 系統的監管核准
      • 提高 CGM 系統在家庭醫療保健中的採用率
    • 抑制因素
      • CGM 設備副作用的發生與準確性限制
    • 機會
      • 技術進步和 CGM 系統意識的提高
      • 對非侵入性治療方法和潛在未確診患者群體的偏好增加
    • 任務
      • 報銷和嚴格監管問題
  • 市場區隔分析
    • 組件：提高 CGM 系統中發送器和接收器的利用率，以實現即時血糖監測
    • 人口統計：兒童CGM 系統的持續進步使其更有效且侵入性更小
    • 患者類型：CGM 系統在第 1 型糖尿病患者中的重要性日益增加。高精度、最小延遲時間以及針對快速血糖值變化的預測警報
    • 最終用戶：具有遠端資料共用功能的CGM系統越來越受到家庭患者的青睞
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章連續血糖監測系統市場：依組成部分

  • 整合胰島素泵
  • 感應器
  • 發送器和接收器

第7章按人口統計的連續血糖監測系統市場

  • 成年人口
  • 兒童人口

第8章連續血糖監測系統市場（依病患類型）

  • 1型糖尿病
  • 2型糖尿病

第9章連續血糖監測系統市場：依最終用戶分類

  • 診斷中心和診所
  • 家庭保健
  • 加護病房

第10章連續血糖監測系統市場：按分銷管道

  • 向機構投資者出售
  • 零售銷售

第11章美洲連續血糖監測系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太連續血糖監測系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲/中東/非洲連續血糖監測系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • Civionix 的 GS1 連續血糖監測系統獲得 CE 標誌
    • Dexcom 針對美國人推出新的 CGM，針對不使用胰島素的糖尿病患者
    • 美國FDA核准Abbott 的 Freestyle Libre 2 和 Freestyle Libre 3 感測器與自動胰島素給藥系統整合

第15章競爭組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-43676CF422F8

[191 Pages Report] The Continuous Glucose Monitoring Systems Market size was estimated at USD 5.54 billion in 2023 and expected to reach USD 6.21 billion in 2024, at a CAGR 12.37% to reach USD 12.55 billion by 2030.

Continuous Glucose Monitoring Systems (CGMS) are advanced medical devices designed to provide real-time glucose readings at regular intervals, typically every few minutes, 24/7. These systems comprise a small sensor that transmits the data wirelessly to a display device, which could be a dedicated receiver, a smartphone, or a smartwatch, enabling the user to monitor their glucose levels without the requirement of traditional fingerstick blood tests. The growing preponderance of diabetes across the globe and the rising awareness of the benefits of continuous glucose monitoring over traditional blood glucose monitoring are driving the market growth. However, devices' high prices and lack of uniform reimbursement can limit market penetration. Inaccuracies in glucose readings due to device calibration issues or interference from external factors also pose a challenge. Furthermore, leveraging big data and advanced analytics to improve predictive capabilities, personalization, and clinical outcomes creates potential opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 5.54 billion
Estimated Year [2024] USD 6.21 billion
Forecast Year [2030] USD 12.55 billion
CAGR (%) 12.37%

Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring

Integrated insulin pumps are devices that deliver insulin automatically based on the set basal rate and work in conjunction with continuous glucose monitoring (CGM) systems. They adjust the insulin delivery based on real-time glucose readings. This feature greatly contributes to the seamless management of blood glucose levels in diabetes patients, especially useful for those with intensive insulin therapy needs or those with Type 1 diabetes. Sensors are a crucial part of CGM systems, as they are the components that measure levels of glucose in the interstitial fluid beneath the skin. CGM sensors typically require changing every 7 to 14 days, depending on the model. Patients who desire minimal intrusion and longer wear times prefer sensors with extended life spans. The transmitter is the part of the CGM system that sends real-time glucose data from the sensor to a receiver and smart device. The receiver is the device that displays the glucose data. Some patients prioritize a system that allows the use of their own smartphone as a receiver, whereas others prefer a dedicated device if they are not comfortable using smart devices.

Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive

Continuous Glucose Monitoring (CGM) systems are crucial for the adult population, especially those diagnosed with Type 1 or Type 2 diabetes. Adults require consistent and accurate monitoring of their blood glucose levels to manage their condition effectively and to prevent acute and long-term complications associated with diabetes. CGM systems for children are designed with special considerations for size, sensitivity, and ease of use, owing to the unique physiological and lifestyle requirements of the pediatric population. These devices help parents and caregivers monitor and manage their child's diabetes more effectively, providing peace of mind and improved quality of life.

Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes

Patients with Type 1 diabetes rely on external insulin because of the autoimmune destruction of the insulin-producing beta cells in the pancreas. Continuous Glucose Monitoring (CGM) systems for this group provide convenience and crucial tools for the management of glucose levels. These patients need real-time data to adjust insulin doses accurately. CGM systems offer significant advantages over traditional blood glucose monitoring, providing detailed insights into glucose trends, which results in better glycemic control and reduction of hypoglycemia risk. Type 2 diabetes patients might not always require insulin but still need to monitor their glucose levels, especially if they are on sulfonylureas and meglitinides, which increase the risk of hypoglycemia. CGM for Type 2 diabetes is geared towards lifestyle management, including diet and exercise, alongside medication. The use of CGM is progressively becoming more common in this group as the technology becomes more affordable and as evidence mounts that it can help improve glycemic control in non-insulin-treated patients.

End User: Growing preference of CGM systems by home patients with remote data sharing capabilities

Diagnostic centers and clinics represent a significant segment for the deployment of Continuous Glucose Monitoring (CGM) systems. These facilities often serve as the initial point of contact for patients experiencing symptoms of diabetes and for those who require ongoing monitoring for their diagnosed condition. Home healthcare represents a rapidly growing segment for CGM systems, as an increasing number of patients with diabetes prefer to manage their condition in the comfort of their own homes. These devices offer convenience and allow for continuous monitoring without the need to visit a healthcare provider frequently. Intensive Care Units (ICUs) are critical settings wherein patients require constant and close monitoring, including for their glucose levels. CGM systems in ICUs must be highly reliable and capable of integrating with other monitoring equipment to ensure a holistic view of a patient's health status.

Regional Insights

The Americas, led by the United States and Canada, show a strong market for CGM systems, aided by higher purchasing power and well-established healthcare systems implementing the latest technologies. The United States & Canada are prominent in CGM technology, with numerous companies researching and developing new systems, evident from a high number of patents filed in this domain. Consumers in the United States have shown an inclination towards maintaining healthy lifestyles, integrating personal health technology with everyday living. There is significant investment and insurance coverage that promotes the use of CGM systems, making them more accessible to the population. European Union countries demonstrate a robust demand for CGM systems, broadly supported by widespread awareness, a push for lifestyle management of diabetes, and favorable insurance reimbursement scenarios. The European Union's medical device sector is tightly regulated, ensuring high standards of product quality and safety. Countries including Germany, France, and the UK are leaders in the adoption of CGM systems. The Middle East, particularly the Gulf Cooperation Council (GCC) countries, has high per capita healthcare spending and is rapidly adopting advanced technologies in healthcare. Asia Pacific is undergoing a surge in the demand for CGM systems due to the increasing prevalence of diabetes and heightened awareness about the disease. The rising popularity of wearable technology for health monitoring indicates a broad consumer need for convenient and non-intrusive healthcare devices in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Continuous Glucose Monitoring Systems Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Continuous Glucose Monitoring Systems Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Dexcom, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, NXP Semiconductors N.V., Senseonics Holdings Inc., Sibionics, STMicroelectronics N.V., Tandem Diabetes Care, Inc., Texas Instruments Incorporated, and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Integrated Insulin Pumps
    • Sensors
    • Transmitters & Receivers
  • Demographics
    • Adult Population
    • Children Population
  • Patient Type
    • Type 1 Diabetes
    • Type 2 Diabetes
  • End User
    • Diagnostic Centers & Clinics
    • Home Healthcare
    • ICUs
  • Distribution Channel
    • Institutional Sales
    • Retail Sales
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Continuous Glucose Monitoring Systems Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Continuous Glucose Monitoring Systems Market?

3. What are the technology trends and regulatory frameworks in the Continuous Glucose Monitoring Systems Market?

4. What is the market share of the leading vendors in the Continuous Glucose Monitoring Systems Market?

5. Which modes and strategic moves are suitable for entering the Continuous Glucose Monitoring Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Number of Incidence of Diabetic Patients Globally
      • 5.1.1.2. Growing Regulatory Approvals for the CGM Systems
      • 5.1.1.3. Growing Adoption Rate of CGM Systems in Home Healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements and Increased Awareness of CGM Systems
      • 5.1.3.2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement and Stringent Regulatory Issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring
    • 5.2.2. Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive
    • 5.2.3. Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes
    • 5.2.4. End User: Growing preference of CGM systems by home patients with remote data sharing capabilities
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Continuous Glucose Monitoring Systems Market, by Component

  • 6.1. Introduction
  • 6.2. Integrated Insulin Pumps
  • 6.3. Sensors
  • 6.4. Transmitters & Receivers

7. Continuous Glucose Monitoring Systems Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adult Population
  • 7.3. Children Population

8. Continuous Glucose Monitoring Systems Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Type 1 Diabetes
  • 8.3. Type 2 Diabetes

9. Continuous Glucose Monitoring Systems Market, by End User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers & Clinics
  • 9.3. Home Healthcare
  • 9.4. ICUs

10. Continuous Glucose Monitoring Systems Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Institutional Sales
  • 10.3. Retail Sales

11. Americas Continuous Glucose Monitoring Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Glucose Monitoring Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Sibionics obtains CE Mark for GS1 continuous glucose monitoring system
    • 14.3.2. Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics
    • 14.3.3. U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 289. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 290. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 291. GERMANY CONTINUOUS GLUC